Theseus Pharmaceuticals Income Statement

Financials in millions JPY. Fiscal year is April - March.

Millions JPY. Fiscal year is Apr - Mar.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021
Revenue	14,072	11,323	8,711	6,877	5,318
Revenue Growth (YoY)	24.28%	29.99%	26.66%	29.32%	-
Cost of Revenue	3,239	2,331	1,420	1,090	809.88
Gross Profit	10,833	8,992	7,291	5,787	4,508
Selling, General & Admin	9,420	7,741	6,201	4,648	4,336
Operating Expenses	9,443	7,756	6,201	4,648	4,336
Operating Income	1,390	1,236	1,090	1,139	172.55
Interest Expense	-14	-3	-	-	-
Interest & Investment Income	-	-	0.01	0.06	0.01
Earnings From Equity Investments	27	74	-	-	-
Other Non Operating Income (Expenses)	2	7	13.47	10.09	9.7
EBT Excluding Unusual Items	1,405	1,314	1,104	1,149	182.26
Gain (Loss) on Sale of Investments	228	-	-3.87	-4.6	-31.52
Gain (Loss) on Sale of Assets	5	-	-	-	-
Asset Writedown	-5	-26	-0.52	-0.33	-23.79
Other Unusual Items	8	-1	-	-	-
Pretax Income	1,641	1,287	1,099	1,144	126.95
Income Tax Expense	592	450	381.81	442.16	62.29
Net Income	1,049	837	717.4	702.28	64.66
Net Income to Common	1,049	837	717.4	702.28	64.66
Net Income Growth	25.33%	16.67%	2.15%	986.09%	-
Shares Outstanding (Basic)	22	22	22	22	22
Shares Outstanding (Diluted)	23	23	23	23	22
Shares Change (YoY)	0.06%	0.14%	-0.71%	2.60%	-
EPS (Basic)	46.67	37.59	32.33	31.56	2.90
EPS (Diluted)	46.04	36.77	31.54	30.65	2.90
EPS Growth	25.21%	16.58%	2.90%	956.90%	-
Free Cash Flow	1,351	1,093	450.99	1,129	556.75
Free Cash Flow Per Share	59.27	47.98	19.82	49.29	24.93
Gross Margin	76.98%	79.41%	83.70%	84.15%	84.77%
Operating Margin	9.88%	10.92%	12.52%	16.56%	3.25%
Profit Margin	7.46%	7.39%	8.24%	10.21%	1.22%
Free Cash Flow Margin	9.60%	9.65%	5.18%	16.42%	10.47%
EBITDA	2,144	1,774	1,357	1,357	334.02
EBITDA Margin	15.24%	15.67%	15.57%	19.73%	6.28%
D&A For EBITDA	754	538	266.4	217.75	161.47
EBIT	1,390	1,236	1,090	1,139	172.55
EBIT Margin	9.88%	10.92%	12.52%	16.56%	3.25%
Effective Tax Rate	36.08%	34.97%	34.73%	38.64%	49.07%
Advertising Expenses	2,031	1,854	-	-	-

Updated Feb 12, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.